Publisher: EurekAlert!


Le Bonheur and UTHSC researcher receives American Lung Association Innovation Award

In the Media Icon

Le Bonheur Children’s Hospital and the University of Tennessee Health Science Center announced today that Amali Samarasinghe, PhD, was awarded the Charles and Amelia Gould Innovation award amounting to $75 thousand over two years through the American Lung Association’s Awards and Grants Program. The Lung Association has committed $11.55 million through 98 awards to fund… Read More


Researcher awarded $1.25 million for HPV vaccination research study

In the Media Icon

The human papillomavirus (HPV) vaccine was introduced in the United States for preteens more than a dozen years ago, yet adherence rates are still below those for other childhood vaccines. Researchers at the University of Tennessee Health Science Center and Emory University have received a major grant totaling $2.7 million from the National Cancer Institute/National… Read More


UTHSC collaborates with Regeneron to advance precision medicine in the mid-south

In the Media Icon

The University of Tennessee Health Science Center has entered into an agreement with the Regeneron Genetics Center, a subsidiary of Regeneron Pharmaceuticals, Inc., for the company to sequence DNA that has been voluntarily collected and stored as part of a biorepository initiative UTHSC is building in collaboration with its partner teaching hospitals. November 18: News… Read More


UTHSC, Regional One Health partner on post-COVID-19 clinic

In the Media Icon

The University of Tennessee Health Science Center and Regional One Health have established a post-COVID-19 clinic to provide specialized outpatient follow-up care to individuals who have tested positive for the virus and may be experiencing long-term symptoms after recovery. The clinic will also be available to individuals who have tested positive for COVID-19 and are… Read More


UTHSC researchers identify three drugs as possible therapeutics for COVID-19

In the Media Icon

Researchers at the University of Tennessee Health Science Center working with colleagues at the University of New Mexico have identified three drugs, already approved for other uses in humans, as possible therapeutics for COVID-19, the illness caused by the SARS-CoV-2 virus. November 18: Citizen Tribune November 18: Fox5 Vegas November 18: USA Life Sciences Database… Read More


Adebiyi receives $3 Million for neonatal kidney research

In the Media Icon

In the transition from fetal to neonatal life, the kidneys undergo delicate and intricate changes in functionality as they assume the primary responsibility for keeping the blood clean and chemically balanced. Understanding these complex physiological changes is critical, as stressors before, during, and after delivery put newborns at risk of kidney injury and maladaptation. The… Read More


Wall awarded $385,000 grant to study amyloidosis treatment options

In the Media Icon

Jonathan Wall, PhD, professor in the University of Tennessee Health Science Center’s Graduate School of Medicine in Knoxville and director of the Amyloidosis and Cancer Theranostics, has been awarded a two-year grant totaling $385,000 from the National Institute on Aging, part of the National Institutes of Health to study new treatments for systemic amyloidosis. Also:… Read More


Mancarella receives $1.5 million to study cardiac muscle deterioration causes

In the Media Icon

Salvatore Mancarella, PhD, associate professor in the Department of Physiology in the College of Medicine at the University of Tennessee Health Science Center, was recently awarded $1.52 million from the National Institutes of Health (NIH) to support his investigations into the molecular-level causes of cardiac muscle deterioration. Also: BioEngineer